Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.

Kouri M, Kankaanranta L, Seppälä T, Tervo L, Rasilainen M, Minn H, Eskola O, Vähätalo J, Paetau A, Savolainen S, Auterinen I, Jääskeläinen J, Joensuu H.

Radiother Oncol. 2004 Jul;72(1):83-5.

PMID:
15236879
2.

Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.

Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Välimäki P, Mäkitie A, Seppänen M, Minn H, Revitzer H, Kouri M, Kotiluoto P, Seren T, Auterinen I, Savolainen S, Joensuu H.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e67-75. doi: 10.1016/j.ijrobp.2010.09.057. Epub 2011 Feb 6.

PMID:
21300462
3.

Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvement.

Kankaanranta L, Saarilahti K, Mäkitie A, Välimäki P, Tenhunen M, Joensuu H.

Radiother Oncol. 2011 Apr;99(1):98-9. doi: 10.1016/j.radonc.2011.02.008. Epub 2011 Mar 11. No abstract available.

PMID:
21397966
4.

1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.

Timonen M, Kankaanranta L, Lundbom N, Collan J, Kangasmäki A, Kortesniemi M, Häkkinen AM, Lönngren A, Karjalainen S, Rasilainen M, Leinonen J, Huitti T, Jääskeläinen J, Kouri M, Savolainen S, Heikkinen S.

Eur J Radiol. 2005 Nov;56(2):154-9.

PMID:
16233888
5.

Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.

Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Mäkitie A, Seppänen M, Minn H, Kotiluoto P, Auterinen I, Savolainen S, Kouri M, Joensuu H.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):475-82. Epub 2007 Aug 6.

PMID:
17689034
6.

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT; Swedish Brain Tumour Study Group.

Radiother Oncol. 2008 Aug;88(2):183-91. doi: 10.1016/j.radonc.2006.04.015. Epub 2008 Mar 11.

PMID:
18336940
7.

[Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].

Pisarev MA, Dagrosa MA, Thomasz L, Juvenal G.

Medicina (B Aires). 2006;66(6):569-73. Review. Spanish.

PMID:
17240633
8.

Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.

Monti Hughes A, Pozzi E, Thorp SI, Curotto P, Medina VA, Martinel Lamas DJ, Rivera ES, Garabalino MA, Farías RO, Gonzalez SJ, Heber EM, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE.

Oral Dis. 2015 Sep;21(6):770-7. doi: 10.1111/odi.12346. Epub 2015 Jun 8.

PMID:
25926141
9.

Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.

Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):829-34.

PMID:
9531367
10.

Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.

Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE.

Radiat Res. 2012 Jan;177(1):59-68. Epub 2011 Oct 10.

PMID:
21980958
11.

In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.

Tilly N, Olsson P, Hartman T, Coderre J, Makar M, Malmquist J, Sjöberg S, Pettersson J, Carlsson J, Glimelius B.

Radiother Oncol. 1996 Jan;38(1):41-50.

PMID:
8850425
12.

Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.

Suzuki M, Sakurai Y, Nagata K, Kinashi Y, Masunaga S, Ono K, Maruhashi A, Kato I, Fuwa N, Hiratsuka J, Imahori Y.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1523-7. Epub 2006 Oct 23.

PMID:
17056200
13.

Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma.

Dagrosa MA, Viaggi M, Longhino J, Calzetta O, Cabrini R, Edreira M, Juvenal G, Pisarev MA.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1084-92.

PMID:
14575840
14.

A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).

Suzuki M, Endo K, Satoh H, Sakurai Y, Kumada H, Kimura H, Masunaga S, Kinashi Y, Nagata K, Maruhashi A, Ono K.

Radiother Oncol. 2008 Aug;88(2):192-5. doi: 10.1016/j.radonc.2008.06.009. Epub 2008 Jul 22.

PMID:
18653257
15.

"Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.

Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Quintana J, Santa Cruz GA, Trivillin VA, Schwint AE.

Radiat Res. 2011 Apr;175(4):463-72. doi: 10.1667/RR2148.1. Epub 2011 Feb 4.

PMID:
21294607
16.

[Boron neutron capture therapy (BNCT) as cancer treatment].

Joensuu H, Kankaanranta L, Tenhunen M, Saarilahti K.

Duodecim. 2011;127(16):1697-703. Review. Finnish.

PMID:
21972588
17.

Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.

Mol Pharm. 2005 Mar-Apr;2(2):151-6.

PMID:
15804189
18.

Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.

Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M.

Oncol Rep. 2007 Oct;18(4):861-6.

PMID:
17786347
19.

Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.

Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1081-6.

PMID:
8600091
20.

Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.

Haginomori S, Miyatake S, Inui T, Araki M, Kawabata S, Takamaki A, Lee K, Takenaka H, Kuroiwa T, Uesugi Y, Kumada H, Ono K.

Head Neck. 2009 Mar;31(3):412-8. doi: 10.1002/hed.20895.

PMID:
18767175

Supplemental Content

Support Center